Regional CBP was measured with the 133Xe inhalation technique before and thrice after smoking mar ijuana of two strengths and placebo in 20 physically and mentally healthy male volunteers with a previous history of exposure to marijuana. They were drug-free at the time of the study. Blood pressure, pulse rate, end-tidal carbon dioxide, end-tidal carbon monoxide, and forehead skin perfusion were quantified during the CBP measurements. Blood samples were drawn for quantification of plasma levels of L\9-tetrahydrocannabinol (THC) before and dur ing the 2 h after smoking marijuana or placebo. Drug induced intoxication and changes in mood were quanti-
fied with rating scales. Marijuana smoking was associated with bilateral CBP increase, which was maximal 30 min later. Greater CBP increases were seen in the frontal re gion and right hemisphere. No significant CBP changes were seen after placebo. Pulse rate and respiration in creased significantly after marijuana but not placebo. Both marijuana and placebo smoking were associated with increased end-tidal carbon monoxide. CBP increase in both hemispheres correlated significantly with degree of intoxication, plasma levels of THC, and pulse rate. Key Words: Cerebral blood flow-Marijuana-Tetrahydro cannabinol.
berg et aI., 1981; Mathew et aI., 1985; Mathew and Wilson, 1991) . Although CBF may be of primary interest in evaluating marijuana-induced changes in brain function, it needs to be pointed out that the drug may influence CBF through other mechanisms as well. The "red eye" seen after marijuana sug gests vasodilation (Ohlsson et aI., 1980; Hollister et aI., 1981) . Marijuana may have a similar vascular effect on brain blood vessels. CBF increases in an oxic (cerebral) conditions (Marshall, 1982; Thomas, 1982) . Marijuana smoking is associated with carbon monoxide production and formation of carboxyhe moglobin (Aranow and Cassidy, 1979) . The associ ated reduction in oxygen delivery to the brain may result in CBF increase. Cerebral blood vessels re ceive vasoconstrictive sympathetic fibers from the superior cervical ganglion (Edvinsson, 1982) . Tachycardia seen after marijuana administration (Ohlsson et aI., 1980; Hollister et aI., 1981) may be due to sympathetic activation. Carbon dioxide is a potent cerebral vasodilator (Maximilian et aI., 1980; Mathew et aI., 1986) , and marijuana smoking may bring about changes in respiration and blood CO2 levels.
In a previous study reported from our laboratory (Mathew et aI., 1989) , marijuana smoking was fol-lowed by CBF decrease in inexperienced marijuana smokers; but in experienced smokers, there was a significant increase. The present study utilized a more thorough study design to evaluate acute changes in regional CBF induced by marijuana smoking.
METHODS

Subjects
Male volunteers who had previous exposure to mari juana were recruited through local advertising (mean ± SO age 25.3 ± 6.4 years). Although some gave a history of abusing other drugs in the past, none had abused any drugs other than marijuana during the previous year. Spe cial attention was paid to alcohol consumption, and sub jects who drank heavily or showed symptoms suggestive of alcohol dependence or abuse (DSM-IIIR) were ex cluded from the project. In addition, the subjects com pleted the Michigan Alcoholism Screening Test (Selzer, 1971) . None of the participants had significant psychiatric disorders at present or in the past. A physical examina tion was performed, and all were found to be in good physical health.
None of the participants had used medicines for 3 months before the study. The subjects were instructed not to consume marijuana or any other drug for 2 weeks before the start and until the end of the study. They were told to avoid alcohol for 24 h and nicotine and caffeine for 4 h (Skinhoj et aI., 1973; Mathew and Wilson, 1985, 1986) before each visit to the laboratory. The research project was described to the subjects, and their informed con sents were obtained. The subjects were paid for partici pation in this study on an hourly basis.
Design
Subjects came to the laboratory on 3 days separated by a minimum of 1 week so that the effects of marijuana administered during one visit would not affect the mea surements made during the next one. In experienced mar ijuana smokers, elimination half-life for �9-tetrahy drocannabinol (THC) is <56 h (Lemberger et aI., 1970 (Lemberger et aI., , 1971 ; thus, a 7-day interval was more than three half lives. A urine drug screen was performed during each visit. CBF was measured four times during each visit, once before and three times after the administration of marijuana or placebo (30, 60, and 120 min).
After the first CBF measurement, the subjects were taken to a room specially equipped with exhaust fans for smoking marijuana/placebo cigarettes. During the three visits, the subjects received a high-potency marijuana cig arette (THC 3.55%), low-potency cigarette (THC 1.75%), and a marijuana placebo cigarette (marijuana after THC was extracted) on a random basis. (Marijuana and pla cebo cigarettes were supplied by the National Institute of Drug Abuse). Neither the subjects nor the laboratory staff knew the identity of the cigarettes. Previous attempts at standardizing the smoking routine resulted in a high inci dence of dysphoric reactions and dizziness without any reduction in the intersubject variations in plasma levels of THC (Mathew et aI., 1989) . Subjects were allowed to smoke ad lib, but they were encouraged to finish the en tire cigarette in 10 min; all of them did so. Two members of the research team remained with the subjects at all times. After 10 min for smoking, the subjects were taken back to the CBF laboratory in a wheelchair (because of possible postural hypotension and dizziness).
After the subjects were brought to the room for mari juana/placebo smoking, an intravenous line was started for blood sample withdrawal. A single 10-ml blood sample was initially taken for hemoglobin (necessary for comput ing CBF). Another lO-ml blood sample was taken before the administration of cigarettes for baseline plasma THC assay, and this was repeated at 5, 10,20,40, and 130 min after the commencement of smoking. �9-THC was as sayed by radioimmunoassay with a kit supplied by the National Institute of Drug Abuse.
Subjects were required to remain in the laboratory until all signs of intoxication had worn off. They were not al lowed to leave the laboratory on their own and either went home in a taxi or were taken home by another in dividual.
CBF measurements
CBF was measured with the 133Xe inhalation technique four times during each visit: once before and thrice after marijuana/placebo. The J33Xe inhalation technique (Obrist et ai., 1975) consisted of the administration of 133Xe, a -v-emitter, through a face mask for 1 min. Air tight seal between the face and the mask was verified by monitoring air from around the mask for radioactivity during and after the administration of the radioisotope. Clearance rate of the isotope from 32 brain regions was traced by applying a helmet with 32 scintillation detec tors mounted on it to the scalp. Position of the helmet with probes relative to the head was standardized by aligning beams of light fixed on the helmet to the outer canthi and external auditory meatus. The clearance curves were analyzed with a bicompartmental model; the fast-clearing component yielded gray matter perfusion values. The second, more slowly clearing compartment, which contained extracranial and white matter flow, was discarded. Xenon recirculation to the brain and radiation from the respiratory passages were also corrected for. Residual radioactivity from the scalp was monitored for 5 min during subsequent measurements and appropriately corrected for.
The first CBF measurement was used for baseline val ues; � 30 min later, marijuana/placebo was administered over a lO-min period. The second CBF measurement was performed 30 min after the drug/placebo, the third mea surement after 60 min, and a fourth after 120 min.
Physiological and rating scale measurements
Blood pressure and pulse were taken before and after each CBF measurement. End-tidal level of carbon diox ide (P eco2) was monitored during the entire procedure.
End-tidal carbon monoxide concentration was estimated by having the subjects exhale fully into a carbon monox ide analyzer before each CBF measurement. Forehead skin perfusion was quantified with a laser-Doppler flow meter (Holloway and Watkins, 1977; Fagrell, 1985) ap plied to the skin �l/2 in above the bridge of the nose. The Profile of Mood States (McNair et aI., 1971) and an ana logue scale to quantify the degree of "high" were admin istered after each CBF measurement.
RESULTS
Procedures of analysis included multivariate analysis of variance for all repeated-measures vari-
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ables, followed when appropriate by t tests (paired) with correction for multiple tests. To examine the relationships among regional CBF, rating scales, and physiological measures, first-order Pearson correlations were employed.
CBF
An analysis of the hemispheric mean flows was performed using a drug/placebo-by-hemisphere-by time model. In this model, drug/placebo repre sented the two doses of marijuana and placebo. The results of this analysis (Figs. 1 and 2) indicated a significant drug/placebo-by-time interaction (F = 3.61, p � 0.02) with significant global increases in CBF following low-and high-dose marijuana.
To examine possible regional CBF differences, this analysis was followed by an analysis of the re gional flow values. Because of the small sample size (n = 20), we elected to use anterior and posterior flows (not the ratio) in each hemisphere, which were determined by computing weighted means (anterior = frontal + central; posterior = temporal + parietal + occipital) as opposed to values from individual regions. This multivariate analysis of variance of the anterior and posterior flows used a drug/placebo-by-time-by-hemisphere-by-anterior posterior model. This analysis indicated a signifi cant drug/placebo-by-time interaction (F = 3.24, df = 6,14, p < 0.033) and a four-way interaction that approached statistical significance (F = 2.75, df = 6,14, p < 0.056). CBF changes were in general more marked in anterior (frontal) as compared with pos terior regions. To explore this four-way interaction, mUltiple paired t tests were conducted on the indi-vidual regions (frontal, central, temporal, parietal, and occipital) . In these analyses, placebo values were compared with low-dose and separately com pared with high-dose values. There were no differ ences at baseline between placebo and low dose or placebo and high dose for either the left or the right hemisphere. At 30 min, there were significant dif ferences between placebo and both low and high dose in the right hemisphere frontal region and for right temporal region after high-dose THC (Table  1) . For the left hemisphere at 30 min, only the pa rietal region had a significant change (t = 4.14, p < 0.05) after high-dose THC. Consistent with the analysis of anterior and posterior, the magnitude of effect (as suggested by the t values) was greater in the frontal regions and was greater in the right hemi sphere than in the left hemisphere, although the di rection of change was the same in the left hemi sphere. Also, significant increase in right frontal CBF persisted into 60 min following smoking high dose marijuana. These same findings were present after correcting CBF for P eco2 using a predeter mined factor of 3% CBF/mm Hg of P eco2 (Maximil ian et aI., 1980). Thus, it would appear that mari juana causes a dose-related increase in global CBF, but it also appears to have regional effects, with a greater increase in the frontal lobe and, in particu lar, in the right hemisphere.
Physiological measures
Plasma levels (ng/ml) were analyzed across time, comparing the low-and high-dose marijuana and placebo sessions. Levels were compared for base line and at 5, 10, 20, 40, and 130 min in the model (Fig. 3) . This analysis indicated a significant drug/ placebo-by-time interaction (F = 6.81, P < 0.001). Peak plasma levels were at 5 min. For both the low-dose and the high-dose conditions, a great deal of variability was present in the plasma levels, with the standard deviation being almost as large as the mean.
The results of analysis of P eco2 indicated no sig nificant change across time and no drug/placebo-by time effect (Table 2) . It should be noted that CBF corrections at 30, 60, and 120 min for differences in Peco2 using standard correction values (3% CBF/ mm Hg Peco2) did not change the results. Analysis of end-tidal carbon monoxide indicated a highly sig nificant increase across time (F = 30.95, p < 0.001; Table 3 ). However, there was no drug/placebo dif ference and no drug/placebo-by-time interaction. Thus, it would appear from the lack of change in the placebo condition that this level of CO did not alter CBF.
Analyses were conducted for the systolic and di astolic blood pressures (Tables 4 and 5 ). Neither systolic nor diastolic blood pressure indicated sig nificant drug/placebo or drug/placebo-by-time ef fects. There was for all three conditions a slight but statistically nonsignificant decrease in systolic blood pressure over the first 40 min. The results of the analysis of pulse rate are consistent with many previous reports of the effect of marijuana on pulse rate (Ohlsson et aI., 1980; Hollister et aI., 1981; Hol lister, 1988) . Pulse rate increased significantly and in a fashion consistent with dose, leading to a highly significant drug/placebo-by-time interaction (F = 9.48, P < 0.001). Peak pulse rate was at 10 min. Analysis of respiration rate indicated a significant time effect for marijuana and placebo sessions, with a slight but statistically significant increase from baseline, with the greatest increase being at 60 min, leading to a significant time effect (F = 6.78, P < 0.004). However, there was no significant drug/ placebo effect and no significant drug/placebo-by time interaction.
Results of the analysis of forehead skin blood flow indicated no significant effects of time or drug/ placebo by time.
Rating scales
Tension and anger (as measured by the Profile of Mood States) showed significant increases after marijuana but not after the placebo (drug/placebo by time; tension, F = 2.38, P < 0.032; anger, F = 2.42, p < 0.029). Figure 4 presents the results of analysis of ratings of intoxication. A significant drug/placebo-by-time effect was indicated (F = 18.68, P "'" 0.001). The ratings changed in a pattern consistent with dose of THC, but there was little difference between the two doses.
Pearson correlations
Separate sets of correlations were determined be tween hemispheric CBF (corrected for Peco2) and physiological measures and the Analogue Rating of Intoxication. These correlations were based on means of the CBF and other scores determined across the 20 subjects, providing 12 data points rep resenting the three drug/placebo sessions and four time points for each session. For the physiological measures, time points were selected to correspond to the time of the CBF measurement. CBF in both hemispheres correlated positively with degree of in toxication. For the physiological measures, THC plasma levels and pulse rate indicated statistically significant correlations with hemispheric CBF val ues (Table 6) .
DISCUSSION
Subjects who participated in the study had previ ous exposure to marijuana; several gave a history of occasional marijuana smoking. Unlike the previous study , none reported anxiety or panic during the study and none experienced any other adverse effects. The analogue rating scale in dicated a significant increase in intoxication ("high") after marijuana. CBF to both hemispheres showed significant increase, with and without car bon dioxide correction, which was maximal 30 min after marijuana. Analysis of regional flow patterns indicated greater increase in the frontal region and the right hemisphere. Perez-Reyes and associates (1982) reported peaking of THC plasma levels dur ing the 10 min of marijuana smoking and sharp re ductions thereafter, similar to our finding. Also sim ilar to previous reports, pulse rate increased signif-icantly, as did respiratory rate (Ohlsson et al., 1980; Hollister et aI., 1981; Hollister, 1988; Mathew et aI., 1989) . Blood pressure, forehead skin blood flow, and P eco2 levels showed no significant changes fol lowing the drug or placebo. End-tidal carbon mon oxide increased to the same degree after the two doses of marijuana and placebo. CBF increase in both hemispheres correlated significantly with de gree of "high," plasma levels of THC, pulse rate, and systolic blood pressure.
As was pointed out earlier, marijuana might in duce CBF changes through mechanisms other than alteration in brain function (Mathew et aI., 1985 (Mathew et aI., , 1986 . However, the results of the present study suggest that altered brain function was mainly re sponsible for the CBF changes (see below). Fore head skin perfusion did not change appreciably af ter marijuana smoking. Forehead skin capillaries re ceive sympathetic innervation from the superior cervical ganglia, which also innervate intracranial blood vessels (Edvinsson, 1982) . Thus, marijuana did not appear to increase sympathetic vasomotor tone. Sympathetic stimulation reduces CBF, but CBF increased after marijuana. Tachycardia seen after marijuana is believed to be due to vagal block ade and not sympathetic stimulation (Weiss et aI., 1972) .
Although marijuana smoking was associated with increased carbon monoxide production (Aranow and Cassidy, 1979) , smoking marijuana cigarettes of two potencies and the placebo produced the same amount of carbon monoxide. Marijuana smoking in creased CBF significantly, but placebo smoking did Drug-by-time interaction (F = 1.42, p = NS). Drug-by-time interaction (F = 1.63, p = NS).
not. Carbon monoxide and CBF did not correlate. Thus, carbon monoxide is unlikely to be responsi ble for the postmarijuana CBF increase. CO2 is a potent cerebrovasodilator, and even modest fluctuations in CO2 cause marked CBF changes (Maximilian et aI. , 1980; Mathew et aI. , 1989) . Marijuana, in the present study, did not in fluence Peco2 levels. Since CO2 has such a potent effect on CBF, it is conceivable that even nonsig nificant changes might influence CBF. However, correction of CBF for changes in Peco2 with a stan dard correction factor did not alter the results.
The role played by the vascular effects of mari juana on cerebral blood vessels is difficult to eval uate (Ohlsson et aI., 1980; Hollister et aI., 1981; Hollister, 1988) . The drug does have a dilative ef fect on conjunctival and muscle blood vessels (Weiss et aI., 1972; Ohlsson et aI. , 1980; Hollister et aI., 1981) . In the present study, marijuana had no effect on forehead skin perfusion. It may be argued that marijuana has a direct effect on cerebral vas culature similar to its dilative effects on conjuncti val and muscle vessels. It needs to be noted that marijuana-induced "red eye" lasts for several hours, while in the present study the CBF increase declined significantly within 2 h after the drug (Ohlsson et aI., 1980; Hollister et aI., 1981) . In spite of the significant correlation between postmarijuana changes in mood and behavioral indexes and re gional CBF and the finding of a regional difference in CBF response, the possibility of drug-induced vascular (cerebral) change cannot be dismissed. CBF is autoregulated, i. e., insulated from mod erate changes in perfusion pressure (Strandgaard and Paulson, 1984) . Thus, marijuana-induced changes in peripheral circulation, which were mod est, were unlikely to influence brain circulation. Marijuana smoking did not bring about significant changes in systolic or diastolic blood pressure in spite of the tachycardia. Pulse rate increase may be related to subjective sensations of intoxication ("feeling high"), which also correlated with hemi spheric CBF.
Although plasma levels of THC and CBF corre lated (first order) significantly, the two followed dif ferent time courses. Previous research has shown differences in the time courses for plasma THC and intoxication after marijuana smoking (Ohlsson et aI., 1980; Hollister et aI., 1981; Perez-Reyes et aI., 1982; Hollister, 1988) . The time course of the CBF changes resembled that of mood changes more closely than plasma THC levels. Experienced marijuana smokers who participated in a previous study also showed a similar postmar ijuana CBF increase. However, in that study, inex perienced smokers who reported severe anxiety showed CBF decrease after marijuana. Findings from a number of studies indicate cerebral vasocon striction during moderate to severe anxiety (Mathew and Wilson, 1990) . None of the subjects who participated in the present study reported sig nificant increases in anxiety after marijuana. The absence of an anxiety response in these subjects can be attributed to two factors. The inexperienced marijuana smokers who participated in our previous study were not currently using marijuana. Partici pants in the study reported here were current, al though infrequent, marijuana users. Adverse reac tions, including anxiety, are more common among inexperienced individuals (Benedikt et aI., 1986; Weil, 1970) . In the previous study, the smoking rou tine was standardized; this resulted in several sub jects receiving more drug than they could "han dle." Many subjects, especially from the inexperi enced group, reported dysphoric reactions and severe anxiety. In the study reported here, the sub jects were allowed to smoke ad libitum although they were encouraged to finish the cigarette in 1 0 min.
The association between marijuana-induced changes in regional CBF and behavior is compli cated and difficult to explain. For some regions in both right and left hemispheres, flow increased sig nificantly after the drug. Global CBF is closely re lated to levels of arousal mediated by the reticular activity system (Nauta, 1971; Mathew and Wilson, 1990) . Conditions associated with high levels of ac tivation show CBF increase, while low arousal states show CBF decrease (Mathew and Wilson, 1990) . Of the various cortical regions, the frontal lobe has the most intimate connections with the thalamus, which mediates arousal (Nauta, 1971; Mathew, 1989 ). In the present study, the CBF in crease after marijuana was most pronounced in the frontal lobe. The right hemisphere has been impli cated in the mediation of emotions, and the most marked CBF changes were seen in the right hemi sphere (Ross, 1984) . It must be noted that frontal flow and global flow correlated with degrees of "high. "
